On March 20, 2020, the Office of the United States Trade Representative (USTR) announced that it was opening a docket to consider additional modifications to tariffs being imposed on China-origin medical-care products...more
On October 16, 2018, the Office of the U.S. Trade Representative (“USTR”) notified the U.S. Congress of the Administration’s intent to negotiate three separate trade agreements with the European Union (“EU”), the United...more
10/23/2018
/ Contract Negotiations ,
EU ,
Free Trade Agreements ,
Japan ,
Obama Administration ,
Trade Agreements ,
Transatlantic Trade and Investment Partnership ,
Trump Administration ,
TTIP ,
UK ,
USTR
On September 17, President Trump announced the imposition of a 10% ad valorem duty on approximately $200 billion worth of Chinese imports, pursuant to Section 301 of the Trade Act of 1974. The Office of the U.S. Trade...more
On July 10, the Office of the United States Trade Representative (USTR) released a list of Chinese products that may become subject to an additional duty of 10% ad valorem, pursuant to Section 301 of the Trade Act of 1974....more